China: Fermentation, Antibiotics And The Need To Modernize

27 November 1995

As the Chinese marketplace moves towards the 21st century and an adoption of western industrial philosophy, there is a momentum to form transnational strategic alliances for access to the technologies of the more-developed world.

In no sector is this truer than that of the Chinese fermentation industry, defined as the collection of enterprises that produce and sell bulk fermentation products for health care, food, feed, industrial or other uses, note consultants Sino Info.

Today in China, the fermentation industry has a strong market orientation, with the level of government direction/involvement varying according to the product. Decisions on what products are to be promoted and in what amounts are often made at the local level, based on the special market conditions that exist in that area. However, some products, vitamin C and citric acid in particular, are being managed more by the state since they have a direct influence on the national economy (vitamin C was in 1994 the largest single US dollar-earning compound within the Chinese pharmaceutical industry, reporting export sales of $41 million).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight